Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more

Recent & Breaking News (NDAQ:VANI)

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Business Wire November 13, 2024

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Business Wire October 22, 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Business Wire September 26, 2024

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Business Wire September 23, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Business Wire September 4, 2024

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire August 28, 2024

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Business Wire August 13, 2024

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Business Wire July 11, 2024

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Business Wire June 13, 2024

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Business Wire May 28, 2024

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Business Wire May 13, 2024

Vivani Medical to Present at TIDES Conference 2024

Business Wire May 9, 2024

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire March 26, 2024

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Business Wire March 6, 2024

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Business Wire March 1, 2024

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Business Wire February 28, 2024

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Business Wire November 14, 2023

Vivani Medical to Present at BIO Investor Forum

Business Wire October 16, 2023

Vivani Medical to Present at the Boulder Peptide Symposium

Business Wire September 7, 2023

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Business Wire September 5, 2023